IMPACT’s Gary Epstein-Lubow, MD of the Stakeholder Engagement Team, and Implementation Core Communications Consultant, John Beilenson, AB, MA, are among the 16 members of a new advisory board established by The National Center to Reframe Aging — the nation’s leading organization dedicated to reshaping the conversation about older people. Members are from diverse professional backgrounds such as communications and public relations, research, policy, and law.
News
IMPACT physicians contribute to Health Affairs article addressing costs of dementia care
Payment For Comprehensive Dementia Care: Five Key Recommendations
February 7, 2023 Continue reading
Vincent Mor to be honored for exceptional career achievement with McKnights Award
IMPACT multiple principal investigator, Vincent Mor, PhD, is to be honored with an McKnight’s Industry Ally Award on March 7, 2023. The first McKnight’s Pinnacle Awards program “recognizes industry veterans who are setting the standards, driving change, providing guidance and inspiring us all,” in senior care, skilled nursing, or the home care sector.
Mor is Professor of Health Services, Policy & Practice; and Florence Pirce Grant University Professor, Brown University School of Public Health at Brown University. His decades-long career in understanding senior care is credited with driving change and setting standards in the field.
The Pinnacle Awards ceremony will be held at the The Ivy Room in Chicago, IL on March 7. Details and tickets are available online.
IMPACT’s Mor is among authors of JAMA article on hospital discharge rates and nursing home quality for those with dementia
IMPACT multiple principal investigator Vincent Mor, PhD recently co-authored an article in Journal of American Medical Association (JAMA) Network Open sharing results of a cross-sectional analysis of Medicare beneficiaries.
The JAMA Network Open article shares a cross-sectional analysis of more than 2 million Medicare beneficiaries hospitalized between 2017 and 2019. The analysis revealed that persons with Alzheimer’s Disease and Related Dementia were more likely to be discharged to lower-quality Skilled Nursing Facilities (SNF) after accounting for discharging hospital, residential neighborhood, and other characteristics (e.g., post-acute care specialization) of all SNFs available at discharge. Results were consistent in analyses stratified by race and ethnicity, payer source, and primary diagnosis.
The article was also covered in McKnight’s to emphasize how the study results show that regulatory and payment changes are “badly needed” to improve the care process and support direct care staff working with dementia patients.
The McKnight article emphasized how the results should cause policymakers to consider incentivizing nursing homes to take patients with Alzheimer’s disease and related dementias (ADRD). The study data showed that these patients often end up in low-quality facilities after a hospital stay. Mor and his colleagues suggested that improving nursing home quality for patients with ADRD will require focused funding efforts to provide quality care.
IMPACT Collaboratory holds 3rd annual training workshop
IMPACT Collaboratory held its 3rd annual Training Workshop and Retreat, “Building Skills to Conduct Embedded Pragmatic Clinical Trials for People Living with Dementia (PLWD) and their Care Partners,” on January 25th and 26th.
The 1.5-day virtual workshop and retreat included 80 participants from 55 institutions. Participants were selected from applications from early to mid-stage researchers seeking to develop competence in designing and conducting ePCTs of interventions to improve care for PWLD and their care partners.
The event featured all new materials focused on building a foundation in practical aspects of designing and conducting ePCTs in Alzheimer’s disease (AD) and AD-related dementias (ADRD) through a combination of activities including: panel discussions, small group sessions, and networking opportunities with experts in the field.
The event was a great success with participants expressing appreciation for the content, interactive sessions and opportunities to network.
IMPACT Collaboratory announces release of funding opportunity RFA for Cycle 5A of Pilot Program
The National Institute on Aging (NIA) Imbedded Pragmatic Alzheimer’s Disease (AD) and AD-Related Dementias (AD/ADRD) Clinical Trials (IMPACT) Collaboratory is pleased to announce a Request for Applications for the Pilot Grants Program Cycle 5A.
In this cycle, the IMPACT Collaboratory will fund up to five 1-year awards for pilot pragmatic clinical trials (ePCTs) that test non-pharmacological interventions embedded in health care system(s) for people living with Alzheimer’s Disease (AD) and AD-related dementias (ADRD) and their care partners. All applications should make a convincing case that the pilot ePCT proposed can take the next step to a full-scale Stage IV effectiveness ePCT, as defined by the National Institutes of Health (NIH). It is anticipated that Pilot Studies will be funded for up to $200,000 in direct costs for a maximum of 12-months (direct costs were raised from $175,000 to $200,000). Applicants from under-represented racial and ethnic groups as well as individuals with disabilities are strongly encouraged to apply for funding. For more information, please see our Pilot Grants Program page.
All applications for pilot ePCTs that evaluate non-pharmacological interventions to improve the care of people living with AD/ADRD and their care partners will be considered. However, this grant cycle will prioritize applications for interventions in these populations that aim to:
- Improve care through behavioral economics “nudge” interventions;
- Reduce inequities in health care;
- Reduce potentially inappropriate medications through de-prescribing; or
- Improve care in emergency departments.
The goal of the pilot projects is to generate the preliminary data necessary to design and conduct a future full-scale Stage IV effectiveness ePCT (based on the NIH Stage Model) funded through other grant mechanisms (NIH or other sources). Preference will be given to applications that address dementia care for populations traditionally marginalized or underrepresented in clinical trials and those that promote health equity.
Informational Webinar
An optional informational webinar will be hosted to provide investigators with an overview of application details and an opportunity to ask questions. Pre-registration is required using the link below.
Tuesday, February 14, 2023, at 12:00pm ET: Registration closed.
Letters of Intent (LOI) – Required
Interested applicants are required to submit an LOI. LOIs are accepted on a rolling basis through:
March 3, 2023 @5PM ET
Full Proposals (By invitation only)
Applications selected for further consideration will be invited to submit a full proposal due:
June 16, 2023 @ 5pm ET
IMPACT HET member María Aranda shares insights on caregiving planning in the New York Times
IMPACT Health Equity Team (HET) member María Aranda PhD, MSW, MPA, LCSW addresses the challenges of developing a caregiving plan in a recent New York Times article. “How to Make a Caregiving Plan (So It’s Ready When You Need It)” features insights from Aranda and other experts. Dr. Aranda shares tips for approaching caregiving conversations and developing a caregiving plan with aging family or friends before they need it.
In order to develop an effective caregiving plan, Aranda recommends communicating directly with those receiving care to better understand their wishes and designating multiple caregivers when possible. She suggests managing expectations and finding resources developed for caregivers.
To read the full article, visit this link.